Investor Relations
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Aug 1, 2019Company’s booth will promote infectious disease products and technology applications for NGS, liquid biopsy, and SNP differentiation
-
Apr 30, 2019Method includes proprietary, single-step closed-tube NGS library prep in 3 hours or less
-
Apr 16, 2019CoSara Diagnostics facility to be among the first of its kind in India
-
Mar 14, 2019Conference hosted at US corporate headquarters to include training for distributors and end-users of Company’s diagnostic, research, and vector-control products
-
Mar 7, 2019Logix Smart™ ZDC Test now available for export from the United States as a CE-marked IVD
-
Feb 26, 2019Company’s multiplexed Logix Smart™ ZDC Test to be available for purchase with CE mark in March 2019
-
Feb 21, 2019Trainings will be conducted for staff and customers of Laboratorios Franja, including demonstrations of Company’s vector control products
-
Jan 30, 2019Transaction included $3M of preferred shares, and the elimination of $2M of debt
-
Jan 23, 2019Presentation coincided with launch of a private-label CoPrimer Product
-
Jan 10, 2019Company Senior Research Scientist will be a guest speaker of LGC, Biosearch
-
Nov 26, 2018Trainings will be conducted for staff and customers of Laboratorios Franja, followed by launch of Company’s products in DR
-
Aug 10, 2018
-
Jun 5, 2018Proof of concept study successful in demonstrating potential SNP multiplexing applications
-
Jun 1, 2018CoPrimers™ used in proof of concept evaluation
-
Apr 6, 2018CODX updates on initial six months as a public company
-
Mar 22, 2018Project moving forward on schedule, with production to begin in Q3 2018
-
Feb 21, 2018Shipment includes 10,000 tests to be sold as Research Use Only by Joint Venture
-
Jan 30, 2018Program received enthusiastically by regional Ministries of Health
-
Dec 19, 2017Laboratory will meet CGMP Requirements of FDA; Will be BSL-2 to allow enhanced in-house verification and validation activities
-
Aug 24, 2017Sales expected upon successful performance evaluation and validation
-
Aug 21, 2017
-
Aug 10, 2017Audit to prepare for eventual sales into the US market
-
Aug 2, 2017
-
Jul 27, 2017
-
Jul 12, 2017